Shareholders of STRATEC SE (Frankfurt: SBS; Prime Standard) approved all agenda items at the company’s Annual General Meeting held on June 23, 2026, including a dividend of EUR 0.60 per share for the 2024 financial year, matching the previous year’s dividend. The total distribution amounts to EUR 7.3 million and will be paid on June 26, 2026, via depositing banks. The meeting, which represented 70.1 percent of the company’s registered share capital, also ratified the actions of the Board of Management and the Supervisory Board. Additionally, shareholders elected PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft (PwC), Frankfurt am Main, as auditor for the 2026 financial year and approved the remuneration report.
The dividend decision reflects the company’s commitment to sharing its financial performance with shareholders, despite a challenging economic environment. STRATEC, which designs and manufactures fully automated analyzer systems for clinical diagnostics and life sciences, has maintained a stable dividend payout, signaling confidence in its operational resilience. The approved dividend underscores the company’s ability to generate cash flow and reward investors while continuing to invest in innovation and growth. STRATEC’s business model involves developing and producing analyzer systems and consumables for partners who market these as complete solutions with their own reagents. The company covers the entire value chain from development to production and quality assurance. Its products are used by laboratories, blood banks, and research institutes worldwide, often based on patented technologies.
The approval of all resolutions, including the remuneration report, indicates shareholder alignment with the company’s strategic direction and governance practices. The high representation of 70.1% of share capital suggests strong investor engagement and confidence in management. Looking ahead, STRATEC’s focus on innovation and partnerships in the diagnostics and life sciences sectors positions it to benefit from ongoing demand for automated laboratory solutions. The company’s shares are traded in the Prime Standard segment of the Frankfurt Stock Exchange, and further details on the meeting and voting results are available at www.stratec.com/agm.
